Department of Medicine (Neurology & Rheumatology), Shinshu University School of Medicine, Japan.
Department of Neurology, Suwa Red Cross Hospital, Japan.
Intern Med. 2020 Sep 15;59(18):2307-2309. doi: 10.2169/internalmedicine.4860-20. Epub 2020 Jun 2.
A 61-year-old Japanese man presented with anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis. NR1 antibodies were detected in his cerebrospinal fluid. Chest computed tomography revealed lung tumor. The patient was diagnosed with paraneoplastic anti-NMDAR encephalitis associated with lung cancer and treated with two cycles of intravenous high-dose methylprednisolone and one cycle of intravenous immunoglobulin. However, he died one year later without improvement. An autopsy confirmed small-cell lung cancer (SCLC). Immunohistochemistry revealed the expression of NR1 subunits in the tumor cells, suggesting that SCLC may trigger NR1 autoimmunity though the expression of NR1 subunits as onconeural antigens, expanding the phenotypic spectrum of paraneoplastic neurological syndrome associated with SCLC.
一位 61 岁的日本男性被诊断为抗 N-甲基-D-天冬氨酸受体(NMDAR)脑炎。他的脑脊液中检测到 NR1 抗体。胸部计算机断层扫描显示肺部肿瘤。该患者被诊断为与肺癌相关的副肿瘤性抗 NMDAR 脑炎,并接受了两个周期的静脉内大剂量甲基强的松龙和一个周期的静脉内免疫球蛋白治疗。然而,一年后他仍没有改善,并死亡。尸检证实为小细胞肺癌(SCLC)。免疫组化显示肿瘤细胞中 NR1 亚单位的表达,提示 SCLC 可能通过表达 NR1 作为神经抗原触发 NR1 自身免疫,扩大了与 SCLC 相关的副肿瘤性神经综合征的表型谱。